Steven Rosenberg

StevenRosenberg

male, 69 years old
Harvard University alumni, Interleukin 2, Surgical oncology, Steven A. Rosenberg, immunotherapy, T cells
Steven A. Rosenberg, M.D., Ph.D., (b. 2 August 1940) is a leading cancer researcher and surgeon. He is credited with developing the use of IL-2 and...

StevenA.Rosenberg

male (Bethesda, Maryland, United States)
MD, PhD, speaker, Chief of surgery, Naitonal Cancer Institute